{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:01:02Z","timestamp":1793113262274,"version":"4.5.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1097\/md.0000000000003302","type":"journal-article","created":{"date-parts":[[2016,5,2]],"date-time":"2016-05-02T18:33:10Z","timestamp":1462213990000},"page":"e3302","source":"Crossref","is-referenced-by-count":50,"title":["Comparative Effectiveness of Blood Pressure-lowering Drugs in Patients who have Already Suffered From Stroke"],"prefix":"10.1097","volume":"95","author":[{"given":"Wei-Ting","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Kai","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chern-En","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Hsien","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Yuan","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Min","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Huan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-34-20210309","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S1474-4422(07)70031-5","article-title":"Preventing stroke: saving lives around the world","volume":"6","author":"Strong","year":"2007","journal-title":"Lancet Neurol"},{"key":"R3-34-20210309","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0140-6736(10)60834-3","article-title":"Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study","volume":"376","author":"O\u2019Donnell","year":"2010","journal-title":"Lancet"},{"key":"R4-34-20210309","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1161\/01.STR.0000092488.40085.15","article-title":"Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review","volume":"34","author":"Rashid","year":"2003","journal-title":"Stroke"},{"key":"R5-34-20210309","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/jama.1974.03230420021019","article-title":"Hypertension-Stroke Cooperative Study Group.","volume":"229","year":"1974","journal-title":"JAMA"},{"key":"R6-34-20210309","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S0140-6736(85)91783-0","article-title":"Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial","volume":"1","author":"Amery","year":"1985","journal-title":"Lancet"},{"key":"R7-34-20210309","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1136\/bmj.293.6561.1570-a","article-title":"Randomised trial of treatment of hypertension in elderly patients in primary care","volume":"293","author":"McCarthy","year":"1986","journal-title":"Br Med J (Clinical research ed"},{"key":"R8-34-20210309","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1001\/jama.265.24.3255","article-title":"Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.","volume":"265","year":"1991","journal-title":"JAMA"},{"key":"R9-34-20210309","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/0140-6736(91)92589-T","article-title":"Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)","volume":"338","author":"Dahlof","year":"1991","journal-title":"Lancet"},{"key":"R10-34-20210309","first-page":"543","article-title":"The Dutch TIA Trial Study Group.","volume":"24","year":"1993","journal-title":"Stroke"},{"key":"R11-34-20210309","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000107813","article-title":"Atenolol in secondary prevention after stroke","volume":"5","author":"Eriksson","year":"1995","journal-title":"Cerebrovasc Dis"},{"key":"R12-34-20210309","first-page":"710","article-title":"Post-stroke antihypertensive treatment study. A preliminary result.","volume":"108","author":"Group","year":"1995","journal-title":"Chinese Med J"},{"key":"R13-34-20210309","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1161\/01.STR.28.12.2557","article-title":"Effect of antihypertensive treatment in patients having already suffered from stroke. Gathering the evidence. The INDANA (INdividual Data ANalysis of Antihypertensive intervention trials) Project Collaborators","volume":"28","author":"Gueyffier","year":"1997","journal-title":"Stroke"},{"key":"R14-34-20210309","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0022-510X(00)00301-4","article-title":"The Scandinavian Multi-Infarct Dementia Trial: a double-blind, placebo-controlled trial on nimodipine in multi-infarct dementia","volume":"175","author":"Pantoni","year":"2000","journal-title":"J Neurol Sci"},{"key":"R15-34-20210309","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/S0140-6736(01)07186-0","article-title":"Blood-pressure reduction and cardiovascular risk in HOPE study","volume":"358","author":"Sleight","year":"2001","journal-title":"Lancet"},{"key":"R16-34-20210309","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(01)06178-5","article-title":"Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.","volume":"358","author":"Group","year":"2001","journal-title":"Lancet"},{"key":"R17-34-20210309","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0195-668X(02)00804-7","article-title":"Effects of a perindopril-based blood pressure lowering regimen on cardiac outcomes among patients with cerebrovascular disease.","volume":"24","author":"Group","year":"2003","journal-title":"Eur Heart J"},{"key":"R18-34-20210309","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1161\/01.STR.0000166048.35740.a9","article-title":"Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study (MOSES)","volume":"36","author":"Schrader","year":"2005","journal-title":"Stroke"},{"key":"R19-34-20210309","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1056\/NEJMoa0804593","article-title":"Telmisartan to prevent recurrent stroke and cardiovascular events","volume":"359","author":"Yusuf","year":"2008","journal-title":"N Engl J Med"},{"key":"R20-34-20210309","doi-asserted-by":"crossref","first-page":"b1665","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ"},{"key":"R21-34-20210309","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/08037050510008823","article-title":"The Study on COgnition and Prognosis in the Elderly (SCOPE): major CV events and stroke in subgroups of patients","volume":"14","author":"Trenkwalder","year":"2005","journal-title":"Blood Press"},{"key":"R22-34-20210309","first-page":"613","article-title":"Effects of blood pressure lowering treatment on stroke recurrence in patients with cerebrovascular diseases: a large-scale, randomized, placebo controlled trial","volume":"33","author":"Liu","year":"2005","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"R23-34-20210309","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1161\/CIRCULATIONAHA.106.653741","article-title":"Secondary prevention of stroke and transient ischemic attack: is more platelet inhibition the answer?","volume":"115","author":"Liao","year":"2007","journal-title":"Circulation"},{"key":"R24-34-20210309","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"34","author":"Mancia","year":"2013","journal-title":"Eur Heart J"},{"key":"R25-34-20210309","doi-asserted-by":"crossref","first-page":"d4891","DOI":"10.1136\/bmj.d4891","article-title":"Management of hypertension: summary of NICE guidance","volume":"343","author":"Krause","year":"2011","journal-title":"BMJ"},{"key":"R26-34-20210309","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcma.2014.11.005","article-title":"2015 guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the management of hypertension","volume":"78","author":"Chiang","year":"2015","journal-title":"J Chin Med Assoc"},{"key":"R27-34-20210309","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"R28-34-20210309","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"key":"R29-34-20210309","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"key":"R30-34-20210309","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1001\/jama.289.19.2534","article-title":"Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis","volume":"289","author":"Psaty","year":"2003","journal-title":"JAMA"},{"key":"R31-34-20210309","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/hr.2009.139","article-title":"Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature","volume":"32","author":"Liu","year":"2009","journal-title":"Hypertens Res"},{"key":"R32-34-20210309","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1177\/0272989X12458724","article-title":"Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials","volume":"33","author":"Dias","year":"2013","journal-title":"Med Decis Making"},{"key":"R33-34-20210309","first-page":"E705","article-title":"Comparative efficacy and safety of six antidepressants and anticonvulsants in painful diabetic neuropathy: a network meta-analysis","volume":"16","author":"Rudroju","year":"2013","journal-title":"Pain Phys"},{"key":"R34-34-20210309","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"R35-34-20210309","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1198\/016214505000001302","article-title":"Assessing evidence inconsistency in mixed treatment comparisons","volume":"101","author":"Lu","year":"2006","journal-title":"J Am Stat Assoc"},{"key":"R36-34-20210309","doi-asserted-by":"crossref","first-page":"f6008","DOI":"10.1136\/bmj.f6008","article-title":"Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis","volume":"347","author":"Wu","year":"2013","journal-title":"BMJ"},{"key":"R38-34-20210309","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2165\/00003495-198428030-00001","article-title":"Indapamide. A review of its pharmacodynamic properties and therapeutic efficacy in hypertension","volume":"28","author":"Chaffman","year":"1984","journal-title":"Drugs"},{"key":"R39-34-20210309","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1038\/399a007","article-title":"The changing landscape of ischaemic brain injury mechanisms","volume":"399","author":"Lee","year":"1999","journal-title":"Nature"},{"key":"R40-34-20210309","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1159\/000323233","article-title":"Recurrence risk after noncardioembolic mild ischemic stroke in a Japanese population","volume":"31","author":"Kono","year":"2011","journal-title":"Cerebrovasc Dis (Basel, Switzerland"},{"key":"R41-34-20210309","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","article-title":"Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients","volume":"359","author":"Jamerson","year":"2008","journal-title":"N Engl J Med"},{"key":"R42-34-20210309","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","article-title":"Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial","volume":"366","author":"Dahlof","year":"2005","journal-title":"Lancet"},{"key":"R43-34-20210309","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000107813","article-title":"Atenolol in secondary prevention after stroke","volume":"5","author":"Eriksson","year":"1995","journal-title":"Cerebrovasc Dis"},{"key":"R44-34-20210309","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/S0140-6736(01)07186-0","article-title":"Blood-pressure reduction and cardiovascular risk in HOPE study","volume":"358","author":"Sleight","year":"2001","journal-title":"Lancet"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000003302","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:21:41Z","timestamp":1620958901000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201604120-00034"}},"subtitle":["Traditional and Bayesian Network Meta-analysis of Randomized Trials"],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":42,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000003302","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]}}}